ID   Ubigene T98G TPCN2 KO
AC   CVCL_E1CK
SY   TPCN2 Knockout cell line (T98G)
DR   Ubigene; YKO-H793
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 20820; TPCN2.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 16051; PARD3; Unexplicit; Ex3-20del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 9588; PTEN; Simple; p.Leu42Arg (c.125T>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0556 ! T98G
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//